-
公开(公告)号:US09872922B2
公开(公告)日:2018-01-23
申请号:US15176452
申请日:2016-06-08
Applicant: PFIZER, INC. , ABBVIE STEMCENTRX LLC
Inventor: Marc Isaac Damelin , Kiran Manohar Khandke , Puja Sapra , Alexander John Bankovich , Scott J. Dylla
IPC: A61K39/395 , A61K47/48 , A61K31/704 , C07K16/30 , A61K47/68
CPC classification number: A61K47/6849 , A61K31/704 , A61K47/6807 , A61K47/6851 , C07K16/30 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/77
Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
-
公开(公告)号:US09381205B2
公开(公告)日:2016-07-05
申请号:US14525442
申请日:2014-10-28
Applicant: Pfizer, Inc. , Stem CentRx, Inc.
Inventor: Marc Isaac Damelin , Kiran Manohar Khandke , Puja Sapra , Alexander John Bankovich , Scott J. Dylla
IPC: A61K39/395 , A61K31/704 , A61K47/48 , C07K16/30
CPC classification number: A61K47/6849 , A61K31/704 , A61K47/6807 , A61K47/6851 , C07K16/30 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/77
Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
Abstract translation: 本发明提供抗EFNA4抗体 - 药物偶联物及其制备和使用方法。
-